Analysis of the passage of the marine biotoxin okadaic acid through an in vitro human gut barrier

Toxicology

Volumn 279, Issue 1-3, 2011, Pages 196-202

  Ehlers, Anke ^a   Scholz, Jana ^a   These, Anja ^a   Hessel, Stefanie ^a   Preiss Weigert, Angelika ^a   Lampen, Alfonso ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

Bioavailability; Caco 2 model; Distribution; Marine biotoxins; Okadaic acid; Toxicokinetic

Indexed keywords

OKADAIC ACID;

ABDOMINAL PAIN; ACTIVE TRANSPORT; ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CELL STRAIN CACO 2; CELL TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; DIARRHEA; DIETARY INTAKE; EFFUSION; EMBRYOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM; MARINE BIOLOGY; MOUSE; NAUSEA; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RISK ASSESSMENT; SHELLFISH POISONING; TOXICOKINETICS; TOXIN SYNTHESIS; VOMITING;

BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTESTINAL ABSORPTION; MARINE TOXINS; OKADAIC ACID; TISSUE DISTRIBUTION;

BIVALVIA; DINOPHYCEAE; MOLLUSCA; MUS;

EID: 78650014064     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.11.001     Document Type: Article

References (48)

1. Aonuma S., Ushijima T., Nakayasu M., Shima H., Sugimura T., Nagao M. Mutation-induction by okadaic acid, a protein phosphatase inhibitor, in Chl cells, but not in Salmonella typhimurium. Mutation Research 1991, 250:375-381.
2. Borst P., Elferink R.O. Mammalian ABC transporters in health and disease. Annual Review of Biochemistry 2002, 71:537-592.
3. Boulenc X., Bourrie M., Fabre I., Roque C., Joyeux H., Berger Y., Fabre G. Regulation of cytochrome-P450Ia1 gene-expression in a human intestinal-cell line, Caco-2. Journal of Pharmacology and Experimental Therapeutics 1992, 263:1471-1478.
4. Buesen R., Mock M., Seidel A., Jacob J., Lampen A. Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes. Toxicology and Applied Pharmacology 2002, 183:168-178.
5. Casarini L., Franchini A., Malagoli D., Ottaviani E. Evaluation of the effects of the marine toxin okadaic acid by using FETAX assay. Toxicology Letters 2007, 169:145-151.
6. Cordier S., Monfort C., Miossec L., Richardson S., Belin C. Ecological analysis of digestive cancer mortality related to contamination by diarrhetic shellfish poisoning toxins along the coasts of France. Environmental Research 2000, 84:145-150.
7. Dawson J.F., Holmes C.F. Molecular mechanisms underlying inhibition of protein phosphatases by marine toxins. Frontiers in Bioscience 1999, 4:646-658.
8. Delie F., Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Critical Reviews in Therapeutic Drug Carrier Systems 1997, 14:221-286.
9. Dixit D., Zarate N., Liu L.W.C., Boreham D.R., Huizinga J.D. Interstitial cells of Cajal and adaptive relaxation in the mouse stomach. American Journal of Physiology. Gastrointestinal and Liver Physiology 2006, 291:G1129-G1136.
10. Ebert B., Seidel A., Lampen A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 2005, 26:1754-1763.
11. Ehlers A., Stempin S., Al-Hamwi R., Lampen A. Embryotoxic effects of the marine biotoxin okadaic acid on murine embryonic stem cells. Toxicon 2010, 55:855-863.
12. European Food Safety Authority (EFSA) Marine biotoxins in shellfish - okadaic acid and analogues - Scientific Opinion of the Panel on Contaminants in the Food chain. The EFSA Journal 2008, 1-62.
13. Fessard V., Grosse Y., PfohlLeszkowicz A., PuiseuxDao S. Okadaic acid treatment induces DNA adduct formation in BHK21 C13 fibroblasts and HESV keratinocytes. Mutation Research-Environmental Mutagenesis and Related Subjects 1996, 361:133-141.
14. Honkanen R.E., Codispoti B.A., Tse K., Boynton A.L., Honkanan R.E. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Toxicon 1994, 32:339-350.
15. Hubatsch I., Ragnarsson E.G., Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nature Protocols 2007, 2:2111-2119.
16. Ito E., Yasumoto T., Takai A., Imanishi S., Harada K. Investigation of the distribution and excretion of okadaic acid in mice using immunostaining method. Toxicon 2002, 40:159-165.
17. Krul C., Luiten-Schuite A., Baan R., Verhagen H., Mohn G., Feron V., Havenaar R. Application of a dynamic in vitro gastrointestinal tract model to study the availability of food mutagens, using heterocyclic aromatic amines as model compounds. Food and Chemical Toxicology 2000, 38:783-792.
18. Lampen A., Bader A., Bestmann T., Winkler M., Witte L., Borlak J.T. Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. Xenobiotica 1998, 28:429-441.
19. Lau Y.Y., Chen Y.H., Liu T.T., Li C., Cui X.M., White R.E., Cheng K.C. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability. Drug Metabolism and Disposition 2004, 32:937-942.
20. Le Hegarat L., Fessard V., Poul J.M., Dragacci S., Sanders P. Marine toxin okadaic acid induces aneuploidy in CHO-K1 cells in presence of rat liver postmitochondrial fraction, revealed by cytokinesis-block micronucleus assay coupled to FISH. Environmental Toxicology 2004, 19:123-128.
21. Le Hegarat L., Jacquin A.G., Bazin E., Fessard V. Genotoxicity of the marine toxin okadaic acid, in human Caco-2 cells and in mice gut cells. Environmental Toxicology 2006, 21:55-64.
22. Le Hegarat L., Puech L., Fessard V., Poul J.M., Dragacci S. Aneugenic potential of okadaic acid revealed by the micronucleus assay combined with the FISH technique in CHO-K1 cells. Mutagenesis 2003, 18:293-298.
23. Lennernas H., Nylander S., Ungell A.L. Jejunal permeability: a comparison between the Ussing chamber technique and the single-pass perfusion in humans. Pharmaceutical Research 1997, 14:667-671.
24. Li Y., Yuan H., Yang K., Xu W., Tang W., Li X. The structure and functions of P-glycoprotein. Current Medicinal Chemistry 2010, 17:786-800.
25. Lopez-Rodas V., Maneiro E., Martinez J., Navarro M., Costas E. Harmful algal blooms, red tides and human helath: diarrhetic shellfish poisoning and colorectal cancer. Anales de la Real Academia Nacional de Medicina 2006, 72:391-408.
26. Matias W.G., Creppy E.E. Evidence for enterohepatic circulation of okadaic acid in mice. Toxic Substance Mechanisms 1996, 15:405-414.
27. Matias W.G., Creppy E.E. Transplacental passage of [3H]-okadaic acid in pregnant mice measured by radioactivity and high-performance liquid chromatography. Human & Experimental Toxicology 1996, 15:226-230.
28. Matias W.G., Traore A., Creppy E.E. Variations in the distribution of okadaic acid in organs and biological fluids of mice related to diarrhoeic syndrome. Human & Experimental Toxicology 1999, 18:345-350.
29. Nishina Y., Sumi T., Iwai S.A., Nishimune Y. Effects of protein phosphatase inhibition by okadaic acid on the differentiation of F9 embryonal carcinoma cells. Experimental Cell Research 1995, 217:288-293.
30. Nunbhakdi-Craig V., Machleidt T., Ogris E., Bellotto D., White C.L., Sontag E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. Journal of Cell Biology 2002, 158:967-978.
31. Ritz V., Marwitz J., Sieder S., Ziemann C., Hirsch-Ernst K.I., Quentin I., Steinfelder H.J. Contribution of mdr1b-type P-glycoprotein to okadaic acid resistance in rat pituitary GH(3) cells. Naunyn-Schmiedebergs Archives of Pharmacology 1999, 360:116-121.
32. Singer K.L., Stevenson B.R., Woo P.L., Firestone G.L. Relationship of serine/threonine phosphorylation/dephosphorylation signaling to glucocorticoid regulation of tight junction permeability and ZO-1 distribution in nontransformed mammary epithelial cells. Journal of Biological Chemistry 1994, 269:16108-16115.
33. Suganuma M., Fujiki H., Suguri H., Yoshizawa S., Hirota M., Nakayasu M., Ojika M., Wakamatsu K., Yamada K., Sugimura T. Okadaic acid - an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:1768-1771.
34. Suganuma M., Tatematsu M., Yatsunami J., Yoshizawa S., Okabe S., Uemura D., Fujiki H. An alternative theory of tissue-specificity by tumor promotion of okadaic acid in glandular stomach of Sd rats. Carcinogenesis 1992, 13:1841-1845.
35. Takai A., Bialojan C., Troschka M., Ruegg J.C. Smooth muscle myosin phosphatase inhibition and force enhancement by black sponge toxin. FEBS Letters 1987, 217:81-84.
36. These A., Scholz J., Preiss-Weigert A. Sensitive method for the determination of lipophilic marine biotoxins in extracts of mussels and processed shellfish by high-performance liquid chromatography-tandem mass spectrometry based on enrichment by solid-phase extraction. Journal of Chromatography A 2009, 1216:4529-4538.
37. Tohda H., Nagao M., Sugimura T., Oikawa A. Okadaic acid, a protein phosphatase inhibitor, induces sister-chromatid exchanges depending on the presence of bromodeoxyuridine. Mutation Research 1993, 289:275-280.
38. Traore A., Baudrimont I., Ambaliou S., Dano S.D., Creppy E.E. DNA breaks and cell cycle arrest induced by okadaic acid in Caco-2 cells, a human colonic epithelial cell line. Archives of Toxicology 2001, 75:110-117.
39. Tripuraneni J., Koutsouris A., Pestic L., deLanerolle P., Hecht G. The toxin of diarrheic shellfish poisoning, okadaic acid, increases intestinal epithelial paracellular permeability. Gastroenterology 1997, 112:100-108.
40. Tubaro A., Sosa S., Altinier G., Soranzo M.R., Satake M., Della Loggia R., Yasumoto T. Short-term oral toxicity of homoyessotoxins, yessotoxin and okadaic acid in mice. Toxicon 2004, 43:439-445.
41. Tubaro A., Sosa S., Carbonatto M., Altinier G., Vita F., Melato M., Satake M., Yasumoto T. Oral and intraperitoneal acute toxicity studies of yessotoxin and homoyessotoxins in mice. Toxicon 2003, 41:783-792.
42. Tyrer P., Foxwell A.R., Kyd J., Harvey M., Sizer P., Cripps A. Validation and quantitation of an in vitro M-cell model. Biochemical and Biophysical Research Communications 2002, 299:377-383.
43. Uchiumi T., Kohno K., Tanimura H., Hidaka K., Asakuno K., Abe H., Uchida Y., Kuwano M. Involvement of protein-kinase in environmental stress-induced activation of human multidrug resistance-1 (Mdr1) gene promoter. FEBS Letters 1993, 326:11-16.
44. Usansky H.H., Sinko P.J. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a). Journal of Pharmacology and Experimental Therapeutics 2005, 314:391-399.
45. Vale C., Botana L.M. Marine toxins and the cytoskeleton: okadaic acid and dinophysistoxins. The FEBS Journal 2008, 275:6060-6066.
46. Wang S.J., Scavetta R., Lenz H.J., Danenberg K., Danenberg P.V., Schonthal A.H. Gene amplification and multidrug-resistance induced by the phosphatase-inhibitory tumor promoter, okadaic acid. Carcinogenesis 1995, 16:637-641.
47. Wessel M.D., Jurs P.C., Tolan J.W., Muskal S.M. Prediction of human intestinal absorption of drug compounds from molecular structure. Journal of Chemical Information and Computer Sciences 1998, 38:726-735.
48. Wikmanlarhed A., Artursson P. Cocultures of human intestinal goblet (Ht29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption. European Journal of Pharmaceutical Sciences 1995, 3:171-183.